Vanguard Personalized Indexing Management
IRWD icon

Vanguard Personalized Indexing Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Sell
64,187
-6,931
-10% -$26.7K ﹤0.01% 1752
2026
Q1 		$250K Sell
71,118
-3,721
-5% -$15.3K ﹤0.01% 1708
2025
Q4 		$252K Buy
74,839
+2,133
+3% +$5.54K ﹤0.01% 1607
2025
Q3 		$95.2K Buy
72,706
+22,029
+43% +$22.8K ﹤0.01% 1827
2025
Q2 		$36.3K Buy
+50,677
New +$39.8K ﹤0.01% 1859
2023
Q3 		– Sell
-12,856
Closed -$137K – 1517
2023
Q2 		$137K Buy
+12,856
New +$138K ﹤0.01% 1382

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Personalized Indexing Management's IRWD Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 9.7% in Q2 2026, selling an estimated $26.7K and leaving 64,187 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #1752.

Vanguard Personalized Indexing Management first reported a position in IRWD in Q2 2023 and has held it in 6 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Vanguard Personalized Indexing Management held 64,187 shares of Ironwood Pharmaceuticals worth $270K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 6,931 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $26.7K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1752 holding.
  • Vanguard Personalized Indexing Management first reported a position in Ironwood Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.